SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-10-032355
Filing Date
2010-04-06
Accepted
2010-04-06 12:48:02
Documents
4
Period of Report
2010-05-13
Effectiveness Date
2010-04-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A g22742def14a.htm DEF 14A 762468
2 GRAPHIC g22742g2274200.gif GRAPHIC 2298
3 GRAPHIC g22742g2274201.gif GRAPHIC 1095
4 GRAPHIC g22742g2274202.gif GRAPHIC 1110
  Complete submission text file 0000950123-10-032355.txt   770571
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 10733703
SIC: 2836 Biological Products, (No Diagnostic Substances)